NN Investment Partners Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History

NN Investment Partners Holdings’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$3.2M	Sell	5,683 -492	-8%	-$297K	0.02%	481
2021 Q4	$4.67M	Sell	6,175 -2,902	-32%	-$2.17M	0.02%	422
2021 Q3	$6.77M	Buy	9,077 +3,009	+50%	+$2.25M	0.04%	361
2021 Q2	$3.91M	Buy	6,068 +378	+7%	+$230K	0.02%	451
2021 Q1	$3.25M	Buy	5,690 +375	+7%	+$222K	0.02%	475
2020 Q4	$3.1M	Sell	5,315 -6,769	-56%	-$3.85M	0.02%	454
2020 Q3	$6.23M	Sell	12,084 -2,285	-16%	-$1.16M	0.04%	310
2020 Q2	$6.49M	Buy	14,369 +622	+5%	+$274K	0.04%	295
2020 Q1	$4.82M	Buy	13,747 +4,300	+46%	+$1.58M	0.04%	316
2019 Q4	$3.5M	Buy	9,447 +5,147	+120%	+$1.81M	0.02%	431
2019 Q3	$1.43M	Buy	4,300 +600	+16%	+$196K	0.01%	535
2019 Q2	$1.16M	Buy	+3,700	New	+$1.11M	0.01%	575

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NN Investment Partners Holdings's BIO Position: Q1 2022 in Review

NN Investment Partners Holdings reduced its Bio-Rad Laboratories Class A (BIO) stake by 8% in Q1 2022, selling an estimated $297K and leaving 5,683 shares worth $3.2M. The position accounts for 0.02% of the portfolio, ranked #481.

NN Investment Partners Holdings first reported a position in BIO in Q2 2019 and has held it in 12 quarters since. The position peaked at $6.77M in Q3 2021. 516 funds tracked by Wall St. Rank hold BIO as of Q1 2022.

NN Investment Partners Holdings held 5,683 shares of Bio-Rad Laboratories Class A worth $3.2M as of Q1 2022.
NN Investment Partners Holdings sold 492 Bio-Rad Laboratories Class A shares in Q1 2022, an estimated $297K.
Bio-Rad Laboratories Class A made up 0.02% of NN Investment Partners Holdings's portfolio in Q1 2022, its #481 holding.
NN Investment Partners Holdings first reported a position in Bio-Rad Laboratories Class A in Q2 2019 and has held it in 12 quarters since.
NN Investment Partners Holdings's Bio-Rad Laboratories Class A position peaked at $6.77M in Q3 2021.
516 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.